A carregar...

Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A

The risk for inhibitor development in mild hemophilia A (factor VIII levels between 5 and 40 U/dL) is larger than previously anticipated, continues throughout life, and is particularly associated with certain mutations in F8. Desmopressin may reduce inhibitor risk by avoiding exposure to FVIII conce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Castaman, Giancarlo, Fijnvandraat, Karin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4192746/
https://ncbi.nlm.nih.gov/pubmed/25139352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-02-546127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!